These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6615699

  • 21. Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
    Taylor YC, Sawyer JM, Hsu B, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1603-7. PubMed ID: 6480448
    [Abstract] [Full Text] [Related]

  • 22. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH, Wallen CA, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [Abstract] [Full Text] [Related]

  • 23. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M, McNally NJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [Abstract] [Full Text] [Related]

  • 24. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
    Stewart FA, Denekamp J, Randhawa VS.
    Br J Cancer; 1982 Jun; 45(6):869-77. PubMed ID: 7093121
    [Abstract] [Full Text] [Related]

  • 25. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.
    Taylor YC, Evans JW, Brown JM.
    Cancer Res; 1983 Jul; 43(7):3175-81. PubMed ID: 6850627
    [No Abstract] [Full Text] [Related]

  • 27. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR.
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [Abstract] [Full Text] [Related]

  • 28. Effect of thiol manipulation on chemopotentiation by nitroimidazoles.
    Siemann DW, Flaherty AA, Penney DP.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1341-5. PubMed ID: 2715088
    [Abstract] [Full Text] [Related]

  • 29. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 May; 8(3-4):639-42. PubMed ID: 7107389
    [Abstract] [Full Text] [Related]

  • 30. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M, Wong KH, Reynolds R, Begley J.
    Int J Hyperthermia; 1995 May; 11(3):379-88. PubMed ID: 7636324
    [Abstract] [Full Text] [Related]

  • 31. Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols.
    Roizin-Towle L, Hall EJ, Flynn M, Biaglow JE, Varnes ME.
    Int J Radiat Oncol Biol Phys; 1982 May; 8(3-4):757-60. PubMed ID: 7107410
    [Abstract] [Full Text] [Related]

  • 32. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I, Guttman P.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):663-6. PubMed ID: 7107395
    [Abstract] [Full Text] [Related]

  • 35. Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levels.
    DeGraff WG, Russo A, Friedman N, Mitchell JB.
    Eur J Cancer; 1990 Jan; 26(1):17-20. PubMed ID: 2138473
    [Abstract] [Full Text] [Related]

  • 36. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(3-4):675-82. PubMed ID: 7050043
    [Abstract] [Full Text] [Related]

  • 37. Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitro.
    Lee FY, Workman P, Cheeseman KH.
    Biochem Pharmacol; 1987 Apr 15; 36(8):1349-55. PubMed ID: 3593422
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic interaction of BCNU and misonidazole in humans.
    Urtasun RC, Tanasichuk H, Fulton D, Raleigh J, Rabin HR, Turner R, Koziol D, Agboola O.
    Int J Radiat Oncol Biol Phys; 1982 Apr 15; 8(3-4):381-6. PubMed ID: 7107356
    [Abstract] [Full Text] [Related]

  • 39. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
    Honess DJ, Workman P, Morgan JE, Bleehen NM.
    Br J Cancer; 1980 Apr 15; 41(4):529-40. PubMed ID: 7387851
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the DNA cross-linking activity of nitrogen mustard by misonidazole and diethyl maleate in a mouse fibrosarcoma tumor in vivo.
    Murray D, Meyn RE.
    Cancer Res; 1984 Jan 15; 44(1):91-6. PubMed ID: 6690065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.